0000935836-25-000375.txt : 20250515
0000935836-25-000375.hdr.sgml : 20250515
20250515155153
ACCESSION NUMBER: 0000935836-25-000375
CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250515
DATE AS OF CHANGE: 20250515
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-87872
FILM NUMBER: 25952140
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 230
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 230
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: LYTTON LAURENCE W
CENTRAL INDEX KEY: 0001105806
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
MAIL ADDRESS:
STREET 1: 467 CENTRAL PARK WEST
CITY: NY
STATE: NY
ZIP: 10025
SCHEDULE 13G/A
1
primary_doc.xml
SCHEDULE 13G/A
0000935836-24-000693
0001105806
XXXXXXXX
LIVE
2
Common Stock, par value $0.0001
03/31/2025
0001403708
Evoke Pharma Inc
30049G302
420 STEVENS AVENUE
SUITE 230
SOLANA BEACH
CA
92075
Rule 13d-1(c)
Lytton, Laurence W.
X1
61274.00
0.00
61274.00
0.00
61274.00
N
3.9
IN
The shares of the Common Stock reported herein consist of warrants to purchase 61,274 shares of Common Stock. The percentages reported in this Schedule 13G are based on 1,492,858 shares of Common Stock outstanding as of May 1, 2025, as reported in the Form 10-Q filed by the Issuer on May 13, 2025.
Evoke Pharma Inc
420 Stevens Avenue, Suite 370, Solana Beach, CA 92075
Laurence W. Lytton
467 Central Park West
New York, NY 10025
United States
Y
61,274.00
3.9%
61,274.00
0
61,274.00
0
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Lytton, Laurence W.
/s/ Laurence W. Lytton
Reporting person
05/15/2025